Ovarian Cancer
Ovarian cancer is a type of cancer that begins in the ovaries, often causing symptoms like abdominal bloating, pelvic pain, and changes in bowel habits. It can be associated with genetic mutations such as BRCA.
Ovarian Cancer: Continued Treatment with Olaparib
We are providing ongoing treatment with Olaparib for patients who have benefited from it in a previous study. This trial focuses on monitoring safety while allowing continued access to the medication.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Breast Cancer
Breast cancer is a disease where malignant cells form in the tissues of the breast, leading to symptoms such as lumps in the breast, changes in breast shape, and discharge from the nipple.
Prostate Cancer
Prostate cancer is a common cancer in men that occurs in the prostate gland, often leading to symptoms like difficulty urinating, blood in urine, and pelvic discomfort.
Endometrial Cancer
Endometrial cancer starts in the lining of the uterus and can cause symptoms such as abnormal vaginal bleeding, pelvic pain, and weight loss.
Pancreatic Cancer
Pancreatic cancer is a type of cancer that begins in the pancreas, often leading to symptoms like abdominal pain, weight loss, and jaundice.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you currently experiencing any serious side effects from your treatment that require stopping it?
- Are you taking any medications that are not allowed in this study?
- Have you been permanently taken off a previous study due to worsening of your disease?
- Are you currently receiving treatment that is not part of this study?
- Are you still benefiting from your current treatment with an AstraZeneca drug?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
0501: Gynaecologische Oncologie
Heverlee, Belgium
Centre Hospitalier Universitaire Dinant Godinne Sainte-Elisabeth-UCL-Namur
0502: Oncology
Saint-Servais, Belgium
Complex Oncological Center Plovdiv EOOD
0907
Plovdiv, Bulgaria
Sponsor: AstraZeneca AB
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.